J&J | JNJ - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -6.66B 3.39B 2026-03
Abbott USD 52.06B 69M 2026-03
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Baxter International USD 6.04B 86M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
CONMED USD 1.02B 15.42M 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 48.99B 128M 2025-12
Merck USD 45.88B 6.73B 2026-03
Merit Medical Systems USD 1.63B 42.42M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.81B 1.1B 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03
Zoetis USD 3.23B 98M 2026-03